Baseline factors identified for the prediction of good responders in patients with end-stage diffuse coronary artery disease undergoing intracoronary CD34+ cell therapy.
Pei-Hsun SungHsin-Ju ChiangYi-Chen LiJohn Y ChiangChi-Hsiang ChuPei-Lin ShaoFan-Yen LeeMel S LeeHon-Kan YipPublished in: Stem cell research & therapy (2020)
This is a retrospective analysis based on phase I ( ISRCTN72853206 ) and II ( ISRCTN26002902 ) clinical trials.
Keyphrases
- cell therapy
- coronary artery disease
- clinical trial
- stem cells
- mesenchymal stem cells
- percutaneous coronary intervention
- st elevation myocardial infarction
- cardiovascular events
- low grade
- coronary artery bypass grafting
- phase ii
- nk cells
- cardiovascular disease
- type diabetes
- double blind
- bone marrow
- high grade
- acute coronary syndrome